12th International Congress on Myeloproliferative Neoplasms

 

12th International Congress on Myeloproliferative Neoplasms
Avatar

What Are the Risk Factors for Accelerated/Blast Phase MPN and the Outcomes of Conventional Treatment Approaches?

By 12th International Congress on Myeloproliferative Neoplasms FEATURING Olatoyosi Odenike
By 12th International Congress on Myeloproliferative Neoplasms FEATURING Olatoyosi Odenike
24 views
November 12, 2019
Comments 0
Login to view comments. Click here to Login
Latest Advances in Myeloproliferative Neoplasms
19:58
12th International Congress on Myeloproliferative Neoplasms

How Should We Treat Children w/ MPN: No Guidelines on Cytoreduction …

Feat. N. Kucine
22:49

Old and New Myelofibrosis (MF) Classifications, When to Consider Tra…

12th International Congress on Myeloproliferative Neoplasms

H. Deeg

36 views
28:48

Introduction to Hypoxia and Erythropoiesis in the Context of High Al…

12th International Congress on Myeloproliferative Neoplasms

J. Prchal

36 views
26:03

Moving Beyond JAKi: Ruxolitinib Failure, Newly Approved and in Devel…

12th International Congress on Myeloproliferative Neoplasms

N. Pemmaraju

117 views
28:30

Is There a Role of Transplantation for CML in the Era of TKIs?

12th International Congress on Myeloproliferative Neoplasms

K. van Besien

22 views
16:32

What Are the Risk Factors for Accelerated/Blast Phase MPN and the Ou…

12th International Congress on Myeloproliferative Neoplasms

O. Odenike

24 views
08:25

What is the Molecular Landscape of Blast Phase MPN and the Implicati…

12th International Congress on Myeloproliferative Neoplasms

O. Odenike

20 views
06:52

Targeting Dysregulated Iron Metabolism in Polycythemia Vera (PV) Pat…

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

20 views
08:25

Therapeutic Options for Treating MPNs are Finally Expanding: Targeti…

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

170 views
11:27

Therapeutic Options for MPNs are Finally Expanding: Immunotherapies …

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

26 views
17:00

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-F…

12th International Congress on Myeloproliferative Neoplasms

R. Silver

25 views
07:54

Update on Long Acting Interferons in MPN: Who Should Be Treated, Who…

12th International Congress on Myeloproliferative Neoplasms

H. Gisslinger

27 views
25:17

Wrangling the MPN-Related Symptom Burden: Specific Symptoms and Etio…

12th International Congress on Myeloproliferative Neoplasms

R. Scherber

174 views
26:23

Update on Myeloid Variant Hypereosinophilia Syndrome: Clinical Subty…

12th International Congress on Myeloproliferative Neoplasms

A. Klion

39 views
30:14

Tales from the Clinic on Essential Thrombocytosis: No Therapy for As…

12th International Congress on Myeloproliferative Neoplasms

J. Spivak

54 views
13:55

Review of JAK2V617F and the Concept of the VAF

12th International Congress on Myeloproliferative Neoplasms

A. Moliterno

25 views
20:40

Review of JAK2V617F VAF Associations in the Context of MPN and CHIP:…

12th International Congress on Myeloproliferative Neoplasms

A. Moliterno

27 views